Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GERON CORP | 750,000 | reported | 16 Feb 2022 | tx 4+2,091,375 |
| Syndax Pharmaceuticals Inc | 49,000 | reported | 04 Feb 2026 | tx 3+84,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Feb 2026 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 24,000 | 0.00 USD | |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 25,000 | 0.00 USD | |
| 15 May 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 35,000 | 0.00 USD | deriv |
| 16 Feb 2022 | GRANT_AWARD | GERON CORP | 750,000 | 0.00 USD | deriv |
| 02 Feb 2021 | GRANT_AWARD | GERON CORP | 300,000 | 0.00 USD | deriv |
| 12 Feb 2020 | GRANT_AWARD | GERON CORP | 291,375 | 0.00 USD | deriv |
| 30 Jan 2019 | GRANT_AWARD | GERON CORP | 750,000 | 0.00 USD | deriv |